Applied DNA Sciences (FRA:UDJ) EBIT per Share : €-18.75 (TTM As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Applied DNA Sciences EBIT per Share?

Applied DNA Sciences's EBIT per Share for the three months ended in Mar. 2024 was €-3.82. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €-18.75.

During the past 3 years, the average EBIT per Share Growth Rate was 36.00% per year. During the past 5 years, the average EBIT per Share Growth Rate was 44.80% per year. During the past 10 years, the average EBIT per Share Growth Rate was 31.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Applied DNA Sciences's EBIT per Share or its related term are showing as below:

FRA:UDJ' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 1 Med: 27.85 Max: 72.8
Current: 36

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Applied DNA Sciences was 72.80% per year. The lowest was 1.00% per year. And the median was 27.85% per year.

FRA:UDJ's 3-Year EBIT Growth Rate is ranked better than
89.6% of 173 companies
in the Medical Diagnostics & Research industry
Industry Median: -2.2 vs FRA:UDJ: 36.00

Applied DNA Sciences's EBIT for the three months ended in Mar. 2024 was €-3.33 Mil.

Applied DNA Sciences EBIT per Share Historical Data

The historical data trend for Applied DNA Sciences's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Applied DNA Sciences EBIT per Share Chart

Applied DNA Sciences Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

EBIT per Share

Get a 7-Day Free Trial

-166.89

-54.30

-30.78

-31.50

-15.69

Applied DNA Sciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial															-3.92	-4.09	-5.76	-5.08	-3.82

Applied DNA Sciences EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Applied DNA Sciences's EBIT per Share for the fiscal year that ended in Sep. 2023 is calculated as

	EBIT per Share		(A: Sep. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-10.263	/	0.654
=	-15.69

Applied DNA Sciences's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-3.329	/	0.871
=	-3.82

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-18.75

Applied DNA Sciences (FRA:UDJ) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Applied DNA Sciences EBIT per Share Related Terms

Thank you for viewing the detailed overview of Applied DNA Sciences's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Applied DNA Sciences (FRA:UDJ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Applied DNA Sciences Inc (FRA:UDJ) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

APDN:USA UDJP:Germany

Address

50 Health Sciences Drive, Stony Brook, New York, NY, USA, 11790

Website

https://www.adnas.com

Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.

Applied DNA Sciences (FRA:UDJ) Headlines

No Headlines